Brief: X4 Pharmaceuticals Q4 Net Income USD -39.821 Million
25/03/2025 10:01
Mar 25 (Reuters) - X4 Pharmaceuticals Q4 income from operations USD -35.715 million. Q4 operating expenses USD 37.149 million
Recent news on X4 Pharmaceuticals
See all newsBrief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
X4 Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: X4 Pharmaceuticals Q2 Operating Expenses USD 25.197 Million
X4 Pharmaceuticals Inc expected to post a loss of 18 cents a share - Earnings Preview
Brief: X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule